Carafe Drug Innovation LLC

Cornerstone Pharmaceuticals is a biopharmaceutical company based in Cranbury, NJ, focused on developing innovative antimetabolic therapies for cancer treatment. The company is currently advancing its lead drug candidate, CPI-613 (devimistat), through preclinical models to explore its efficacy in combination therapies. With a commitment to research and development, Cornerstone Pharmaceuticals aims to revolutionize cancer care by targeting the metabolic pathways that fuel tumor growth. Their strategic approach reflects a dedication to improving patient outcomes through novel therapeutic solutions. Generated from the website

Aurobindo Pharma USA Inc, located in East Windsor, NJ, is a fully integrated pharmaceutical company with a global presence, exporting to over 150 countries worldwide. Committed to quality and safety, Aurobindo Pharma features among the top 2 companies in India in terms of consolidated revenues, with more than 90% of its revenues derived from international operations. With a robust product portfolio and a team of 1,700 expert scientists and analysts globally, Aurobindo Pharma leverages India's competitive cost base to successfully launch affordable products across multiple therapeutic areas and delivery technologies. From discovery to development to commercialization, the company's growth is supported by cost-effective drug development and substantial manufacturing capabilities. Generated from the website